Your browser doesn't support javascript.
loading
Structural basis of drugs that increase cardiac inward rectifier Kir2.1 currents.
Gómez, Ricardo; Caballero, Ricardo; Barana, Adriana; Amorós, Irene; De Palm, Sue-Haida; Matamoros, Marcos; Núñez, Mercedes; Pérez-Hernández, Marta; Iriepa, Isabel; Tamargo, Juan; Delpón, Eva.
Afiliação
  • Gómez R; Department of Pharmacology, School of Medicine, Universidad Complutense, Madrid 28040, Spain.
  • Caballero R; Department of Pharmacology, School of Medicine, Universidad Complutense, Madrid 28040, Spain Instituto de Investigación Sanitaria Gregorio Marañón, School of Medicine, Universidad Complutense, Madrid 28040, Spain rcaballero@med.ucm.es.
  • Barana A; Department of Pharmacology, School of Medicine, Universidad Complutense, Madrid 28040, Spain Instituto de Investigación Sanitaria Hospital Clínico San Carlos, School of Medicine, Universidad Complutense, Madrid, Spain.
  • Amorós I; Department of Pharmacology, School of Medicine, Universidad Complutense, Madrid 28040, Spain Instituto de Investigación Sanitaria Gregorio Marañón, School of Medicine, Universidad Complutense, Madrid 28040, Spain.
  • De Palm SH; Department of Pharmacology, School of Medicine, Universidad Complutense, Madrid 28040, Spain.
  • Matamoros M; Department of Pharmacology, School of Medicine, Universidad Complutense, Madrid 28040, Spain Instituto de Investigación Sanitaria Gregorio Marañón, School of Medicine, Universidad Complutense, Madrid 28040, Spain.
  • Núñez M; Department of Pharmacology, School of Medicine, Universidad Complutense, Madrid 28040, Spain Instituto de Investigación Sanitaria Gregorio Marañón, School of Medicine, Universidad Complutense, Madrid 28040, Spain.
  • Pérez-Hernández M; Department of Pharmacology, School of Medicine, Universidad Complutense, Madrid 28040, Spain Instituto de Investigación Sanitaria Hospital Clínico San Carlos, School of Medicine, Universidad Complutense, Madrid, Spain.
  • Iriepa I; Department of Organic Chemistry, School of Pharmacy, Universidad de Alcalá, Alcalá de Henares, Spain.
  • Tamargo J; Department of Pharmacology, School of Medicine, Universidad Complutense, Madrid 28040, Spain Instituto de Investigación Sanitaria Hospital Clínico San Carlos, School of Medicine, Universidad Complutense, Madrid, Spain.
  • Delpón E; Department of Pharmacology, School of Medicine, Universidad Complutense, Madrid 28040, Spain Instituto de Investigación Sanitaria Gregorio Marañón, School of Medicine, Universidad Complutense, Madrid 28040, Spain.
Cardiovasc Res ; 104(2): 337-46, 2014 Nov 01.
Article em En | MEDLINE | ID: mdl-25205296

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Propafenona / Ativação do Canal Iônico / Canais de Potássio Corretores do Fluxo de Internalização / Miócitos Cardíacos / Moduladores de Transporte de Membrana / Frequência Cardíaca / Antiarrítmicos Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Propafenona / Ativação do Canal Iônico / Canais de Potássio Corretores do Fluxo de Internalização / Miócitos Cardíacos / Moduladores de Transporte de Membrana / Frequência Cardíaca / Antiarrítmicos Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article